News | Magnetic Resonance Imaging (MRI) | September 17, 2018

Stress Cardiac MRI Shows High Prognostic Value for Suspected Ischemia Patients

Evidence in SPINS cohort supports expanded use of CMR

Stress Cardiac MRI Shows High Prognostic Value for Suspected Ischemia Patients

September 17, 2018 — Raymond Kwong, M.D., MPH, from the Harvard Medical School recently presented his findings on a study of how single-center stress cardiovascular magnetic resonance (CMR) research studies have shown excellent values in management of patients with suspected ischemia. Kwong, who is also a member of the Society for Cardiovascular Magnetic Resonance (SCMR) presented his findings at the 2018 European Society of Cardiology (ESC) Congress, Aug. 25-29 in Munich, Germany.

Numerous single-center studies have demonstrated high diagnostic accuracy and prognostic values of stress CMR in patients with chest pain (CP) syndromes. Multiple guidelines had major recommendations for the use of stress CMR in these settings. Yet utilization of stress CMR in the U.S. is disproportionately low, at  less than 5 percent of noninvasive stress imaging. The SCMR registry can provide real-world multicenter evidence of clinical impact and cost/effectiveness

The objectives of the SPINS study were to:

  • Evaluate the prognostic value of stress CMR in patients presenting with CP syndromes, in a real-world multicenter setting in the U.S.; and
  • As a preliminary analysis, to assess the utilization and costs of cardiac tests, after performance of the index stress CMR study.

“The SPINS cohort is a retrospective observation study from 13 U.S. cardiac MRI centers (9 AMC, 4 private practice) consisting of N=2,371 patients who underwent stress CMR scanning between Jan. 1, 2008 through Dec. 31, 2013, for evaluation of clinical signs and symptoms suspicious of cardiac ischemia,” said Kwong, lead investigator of the study. “Patients overall had a 33 percent pretest likelihood of CAD [coronary artery disease] by CAD consortium scores, and 32 percent were found to have ischemia or myocardial infarction. All patients were aimed to have clinical follow-up of at least four years.

“Stress CMR is an effective modality in the real-world setting in detecting patients at high risk of cardiac events,” said Kwong. “In addition, preliminary costs analyses suggest its use may potentially reduce costs of downstream cardiac testing. Our evidence supports the expanded utilization of stress CMR in evaluation of chest pain syndromes in the United States.”

For more information: www.escardio.org

Related Content

U.S. Soldiers Have Worse Heart Health Than Civilians
News | Cardiac Diagnostics | June 06, 2019
Active duty Army personnel have worse cardiovascular health compared to people of similar ages in the civilian...
Late Dinner and No Breakfast Worsens Outcomes After Heart Attack
News | Cardiac Diagnostics | May 23, 2019
People who skip breakfast and eat dinner near bedtime have worse outcomes after a heart attack, according to research...
HRS Releases New Expert Consensus Statement on Arrhythmogenic Cardiomyopathy
News | Cardiac Diagnostics | May 14, 2019
The Heart Rhythm Society (HRS) released a first-of-its-kind consensus statement with guidance on the evaluation and...
New Best Practices Help Manage Heart Attack Patients Without Significant Signs
News | Cardiac Diagnostics | April 15, 2019
For the first time in the United States, doctors with the American Heart Association (AHA) have outlined best practices...
The most recent U.S. Food and Drug Administration (FDA) clearance was Siemens Healthineers high-sensitivity troponin I assays (TnIH) for the Atellica IM and ADVIA Centaur XP/XPT in vitro diagnostic analyzers. The test helps in the early diagnosis of myocardial infarctions without the need for serial tropic testing. The time to first results is 10 minutes.

The most recent U.S. Food and Drug Administration (FDA) clearance was Siemens Healthineers high-sensitivity troponin I assays (TnIH) for the Atellica IM and ADVIA Centaur XP/XPT in vitro diagnostic analyzers. The test helps in the early diagnosis of myocardial infarctions without the need for serial tropic testing. The time to first results is 10 minutes. 

Feature | Cardiac Diagnostics | March 22, 2019 | Linda C. Rogers, Ph.D.
Troponins are a family of proteins found in skeletal and heart (cardiac) muscle fibers that produce muscular contract
ACC/AHA Update Guidance for Preventing Heart Disease; Stroke
Feature | Cardiac Diagnostics | March 18, 2019
The choices we make every day can have a lasting effect on our heart and vascular health. Adopting a heart healthy...
AHA Statement Warns Hookah Smoking May Harm the Heart
News | Cardiac Diagnostics | March 08, 2019
Smoking tobacco in waterpipes, more commonly known as hookahs, results in inhaling toxic chemicals, often at levels...
PTSD Alone Does Not Increase Heart Disease Risk in Veterans
News | Cardiac Diagnostics | February 20, 2019
February 20, 2019 — Post-traumatic stress disorder (PTSD) by itself does not explain the...
Hormone Therapy May Increase Cardiovascular Risk During Gender Transition
News | Cardiac Diagnostics | February 18, 2019
Patients receiving hormone therapy as part of their gender-transition treatment had an elevated risk for cardiovascular...
Overlay Init